[go: up one dir, main page]

GB2118176B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB2118176B
GB2118176B GB08308056A GB8308056A GB2118176B GB 2118176 B GB2118176 B GB 2118176B GB 08308056 A GB08308056 A GB 08308056A GB 8308056 A GB8308056 A GB 8308056A GB 2118176 B GB2118176 B GB 2118176B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08308056A
Other versions
GB2118176A (en
GB8308056D0 (en
Inventor
Robert Charles Hider
George Kontoghiorghes
Jack Silver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NAT RES DEV
National Research Development Corp UK
Original Assignee
NAT RES DEV
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NAT RES DEV, National Research Development Corp UK filed Critical NAT RES DEV
Priority to GB08308056A priority Critical patent/GB2118176B/en
Publication of GB8308056D0 publication Critical patent/GB8308056D0/en
Publication of GB2118176A publication Critical patent/GB2118176A/en
Application granted granted Critical
Publication of GB2118176B publication Critical patent/GB2118176B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
GB08308056A 1982-03-24 1983-03-24 Pharmaceutical compositions Expired GB2118176B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08308056A GB2118176B (en) 1982-03-24 1983-03-24 Pharmaceutical compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8208608 1982-03-24
GB08308056A GB2118176B (en) 1982-03-24 1983-03-24 Pharmaceutical compositions

Publications (3)

Publication Number Publication Date
GB8308056D0 GB8308056D0 (en) 1983-05-05
GB2118176A GB2118176A (en) 1983-10-26
GB2118176B true GB2118176B (en) 1985-12-04

Family

ID=26282349

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08308056A Expired GB2118176B (en) 1982-03-24 1983-03-24 Pharmaceutical compositions

Country Status (1)

Country Link
GB (1) GB2118176B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8325494D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
EP0180188B1 (en) * 1984-10-30 1992-04-15 Otsuka Pharmaceutical Co., Ltd. A composition for increasing the anti-cancer activity of an anti-cancer compound
US5789426A (en) * 1995-01-20 1998-08-04 Cornell Research Foundation, Inc. Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
EP0768302B1 (en) * 1995-09-29 2005-07-06 Novartis AG Hydroxypyridinones
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease
GR1003358B (en) * 1997-03-12 2000-04-10 �.�. �������� �����������������-����������-������������... Process for producing 1,2-dimethyl-3-hydroxypyrid-4-one
CA2313270C (en) * 2000-06-30 2011-09-13 Apotex Inc. Use of deferiprone in treating and preventing iron-induced cardiac disease

Also Published As

Publication number Publication date
GB2118176A (en) 1983-10-26
GB8308056D0 (en) 1983-05-05

Similar Documents

Publication Publication Date Title
GB8326565D0 (en) Pharmaceutical compositions
GB8327612D0 (en) Pharmaceutical compositions
GB2136807B (en) Pharmaceutical compositions
DE3467703D1 (en) Pharmaceutical compositions
CY1678A (en) Pharmaceutical compositions
ZA834074B (en) Pharmaceutical composition
GB2136806B (en) Pharmaceutical compositions
ZA833781B (en) Pharmaceutical compositions
EP0093551A3 (en) Pharmaceutical composition
CY1503A (en) Pharmaceutical compositions
GB2118176B (en) Pharmaceutical compositions
PT77323A (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
US4594359B1 (en) Pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
EP0136006A3 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
GB8332653D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
7732 Case decided by the comptroller ** patent revoked (sect. 73(2)/1977)